Caribou Biosciences Inc
CRBU
Get informed when a big investor buys or sells
+ FollowMarket Cap$57.12M
Close$
$-1.97
501.2% downside
Current Fair Value
501.2% downsideOvervalued by 501.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $57.12 Million |
|---|---|
| Enterprise Value | $57.95 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.59 |
| Beta | 2.31 |
| Outstanding Shares | 100,985,698 |
Return
| Return on Equity | -105.40% |
|---|---|
| Return on Assets | -72.42% |
| Return on Invested Capital | -87.08% |
Valuation & Multiples
| P/E Ratio | -0.49 |
|---|---|
| PEG | 0.9 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 10.65 |
| Enterprise Value to EBIT | -0.53 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.47 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$2.28 M
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
$-0.36
Average shareholder expectationRevenue Estimate
$2.20 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 39.89% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.02%▼ 48.75% |
|---|---|
| Total Invested | $21,213▼ 99.98% |
| Investors Holding | 3▼ 142.00% |
ESG Score
No data
About Caribou Biosciences Inc
2,021 employees